Literature DB >> 23118146

Assessment of the effects of severe obesity and lifestyle risk factors on stage of endometrial cancer.

Marisa A Bittoni1, James L Fisher, Jeffrey M Fowler, George L Maxwell, Electra D Paskett.   

Abstract

BACKGROUND: Lifestyle risk factors, including obesity, have been associated with increased risk of endometrial cancer (EC). Women with higher obesity levels tend to have less aggressive EC disease stage and histology. This study further investigated associations between nonmodifiable risk factors, such as age, race, and grade, and modifiable lifestyle factors, such as diet and physical activity expenditure, in relation to severe obesity and late versus early EC stage at diagnosis.
METHODS: Demographic, anthropometric, and lifestyle surveys were administered to 177 women with histologically confirmed EC. Logistic regression analyses assessed the relationship between obesity and other risk factors on EC stage at diagnosis.
RESULTS: In multivariate models, body mass index (BMI) < 35 was not significantly associated with late EC stage at diagnosis (OR = 1.67, P = 0.219) when adjusting for grade and age. Grade was significantly associated with EC stage when controlling for BMI and age (OR = 8.48, P = .000). Women more than the age of 60 had a fourfold increased risk of diagnosis at late versus early EC stage when adjusting for other risk factors. Age had a confounding effect on the obesity-EC stage association.
CONCLUSIONS: Our results corroborate those of past studies showing that BMI is not an independent risk factor for EC stage and that age may have confounded the obesity-EC stage association. Because of mixed results and implications for treatment outcomes, however, further research examining these variables is warranted. IMPACT: Our results provide further insight into the obesity EC-stage association, especially the confounding effect of age. Future studies should examine modifiable lifestyle factors in larger and more diverse populations.

Entities:  

Mesh:

Year:  2012        PMID: 23118146      PMCID: PMC3954974          DOI: 10.1158/1055-9965.EPI-12-0843

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  21 in total

Review 1.  The impact of obesity on the incidence and treatment of gynecologic cancers: a review.

Authors:  Susan C Modesitt; John R van Nagell
Journal:  Obstet Gynecol Surv       Date:  2005-10       Impact factor: 2.347

2.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

3.  Morbid obesity and endometrial cancer: surgical, clinical, and pathologic outcomes in surgically managed patients.

Authors:  James C Pavelka; Inbar Ben-Shachar; Jeffrey M Fowler; Nilsa C Ramirez; Larry J Copeland; Lynne A Eaton; Tom P Manolitsas; David E Cohn
Journal:  Gynecol Oncol       Date:  2004-12       Impact factor: 5.482

4.  Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative.

Authors:  Katherine W Reeves; Gebra Cuyun Carter; Rebecca J Rodabough; Dorothy Lane; S Gene McNeeley; Marcia L Stefanick; Electra D Paskett
Journal:  Gynecol Oncol       Date:  2011-02-15       Impact factor: 5.482

5.  Clinical and pathologic correlates in surgical stage II endometrial carcinoma.

Authors:  David E Cohn; Emily M Woeste; Stacey Cacchio; Vanna L Zanagnolo; Laura J Havrilesky; Andrea Mariani; Karl C Podratz; Warner K Huh; Jenny M Whitworth; D Scott McMeekin; Matthew A Powell; Emily Boyd; Gary S Phillips; Jeffrey M Fowler
Journal:  Obstet Gynecol       Date:  2007-05       Impact factor: 7.661

Review 6.  Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship.

Authors:  Amanda Nickles Fader; Lucybeth Nieves Arriba; Heidi E Frasure; Vivian E von Gruenigen
Journal:  Gynecol Oncol       Date:  2009-04-29       Impact factor: 5.482

7.  The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer.

Authors:  E Everett; H Tamimi; B Greer; E Swisher; P Paley; L Mandel; B Goff
Journal:  Gynecol Oncol       Date:  2003-07       Impact factor: 5.482

Review 8.  Stage matters: choosing relevant model systems to address hypotheses in diet and cancer chemoprevention research.

Authors:  Jenifer I Fenton; Norman G Hord
Journal:  Carcinogenesis       Date:  2006-02-10       Impact factor: 4.944

9.  Influence of body mass index on prognosis in gynecological malignancies.

Authors:  Karsten Münstedt; Mathias Wagner; Uwe Kullmer; Andreas Hackethal; Folker E Franke
Journal:  Cancer Causes Control       Date:  2008-04-08       Impact factor: 2.506

10.  Dietary patterns, Mediterranean diet, and endometrial cancer risk.

Authors:  Tapashi B Dalvi; Alison J Canchola; Pamela L Horn-Ross
Journal:  Cancer Causes Control       Date:  2007-07-19       Impact factor: 2.506

View more
  8 in total

1.  Clinical analysis of endometrial cancer patients with obesity, diabetes, and hypertension.

Authors:  Xiang-Hua Yin; Hong-Yan Jia; Xiao-Rui Xue; Shi-Zhang Yang; Zhong-Qin Wang
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 2.  A systematic review and meta-analysis of physical activity and endometrial cancer risk.

Authors:  Daniela Schmid; Gundula Behrens; Marlen Keimling; Carmen Jochem; Cristian Ricci; Michael Leitzmann
Journal:  Eur J Epidemiol       Date:  2015-03-24       Impact factor: 8.082

3.  Referring survivors of endometrial cancer and complex atypical hyperplasia to bariatric specialists: a prospective cohort study.

Authors:  Amelia M Jernigan; Kathryn A Maurer; Karen Cooper; Philip R Schauer; Peter G Rose; Chad M Michener
Journal:  Am J Obstet Gynecol       Date:  2015-05-14       Impact factor: 8.661

4.  Obesity in Patients with Endometrial Cancer: May It Affect the Surgical Outcomes of Laparoscopic Approach?

Authors:  Z M Gambacorti-Passerini; C López-De la Manzanara Cano; C Pérez Parra; M C Cespedes Casas; L Sánchez Hipólito; C Martín Francisco; J R Muñoz-Rodríguez
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

5.  The impact of morbid obesity on survival of endometrial cancer.

Authors:  Ahmet Barış Güzel; Ghanim Khatib; Ümran Küçükgöz Güleç; Derya Gümürdülü; Mehmet Ali Vardar
Journal:  Turk J Obstet Gynecol       Date:  2020-10-02

6.  Body mass index in HER2-negative metastatic breast cancer treated with first-line paclitaxel and bevacizumab.

Authors:  Laura Pizzuti; Domenico Sergi; Isabella Sperduti; Luigi Di Lauro; Marco Mazzotta; Claudio Botti; Fiorentino Izzo; Luca Marchetti; Silverio Tomao; Paolo Marchetti; Clara Natoli; Antonino Grassadonia; Teresa Gamucci; Lucia Mentuccia; Emanuela Magnolfi; Angela Vaccaro; Alessandra Cassano; Ernesto Rossi; Andrea Botticelli; Valentina Sini; Maria G Sarobba; Maria Agnese Fabbri; Luca Moscetti; Antonio Astone; Andrea Michelotti; Claudia De Angelis; Ilaria Bertolini; Francesco Angelini; Gennaro Ciliberto; Marcello Maugeri-Saccà; Antonio Giordano; Maddalena Barba; Patrizia Vici
Journal:  Cancer Biol Ther       Date:  2018-02-16       Impact factor: 4.742

7.  Treatment of endometrial cancer in patient with malignant obesity.

Authors:  Miroslav D Popovic; Arnela Ceric Banicevic; Biljana Popovic; Amela Ceric; Andrija Banicevic; Danijela Popadic
Journal:  Med Arch       Date:  2014

8.  Risk factors for endometrial carcinoma among postmenopausal women in Sri Lanka: a case control study.

Authors:  Withanage Iresha Udayangani Jayawickcrama; Chrishantha Abeysena
Journal:  BMC Public Health       Date:  2019-10-28       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.